Supernus Pharmaceuticals, Inc.
Treatment Of Central Nervous System, Drug Development, Tablets, Capsules, Research & Development
Treatment Of Central Nervous System, Drug Development, Tablets, Capsules, Research & Development
Supernus is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. They market two products, Oxtellar XR and Trokendi XR in the U.S. Oxtellar XR and Trokendi XR are the first once-daily extended release oxcarbazepine and topiramate products indicated for the treatment of epilepsy in the U.S. market.
We have 425 contacts in our database, out of which 17% are decision makers. The distribution of leads are as follows:
In October, 2019 supernus.com's total website visitor was 5213, increased by 181% from previous month. Some key metrics are Average time spent on site is 3 minutes, Bounce Rate is 38% and average page per visit is 4 respectively.
We Verified supernus.com server for email deliverability.
Adobe is a global name in software industry. But software industry has too many participants that...
T-Mobile reached a definitive agreement to acquire the Sprint-branded wireless operating assets o...
Being an American multinational company Cognizant has access to a huge section of the IT industry...
SVB Financial Group to acquire Boston Private, a leading provider of wealth management, trust and...
Amazon.com is a worldwide name in the Internet and E-Commerce industry. Amazon may be termed as t...
© Copyright 2014-2021 by GetCompanyInfo.com. All Rights Reserved.
